Observational study on managing sinonasal and skull-base tumors
Prospective Observational Study of Sinonasal and Skull-base Tumours Management in a Tertiary Referral Otorhinolaryngology Service
This study looks at how patients with sinonasal and skull-base tumors are treated and what their experiences are, to help improve care for these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Sex | All |
| Sponsor | University Medical Centre Ljubljana Academic / other |
| Locations | 1 site (Ljubljana, Ljubljana) |
| Trial ID | NCT05607888 on ClinicalTrials.gov |
What this trial studies
This observational prospective study aims to describe the epidemiology, management, and outcomes of patients with sinonasal and skull-base pathologies at a tertiary otorhinolaryngology referral center. It seeks to understand the caseload of these conditions, the results of their management, the epidemiological characteristics of the patients, and their quality of life. By analyzing these factors, the study hopes to improve the management of sinonasal and skull-base diseases and provide valuable insights for comparison with other centers.
Who should consider this trial
Good fit: Ideal candidates for this study include patients diagnosed with sinonasal and/or skull-base cancer or sinonasal diseases that extend into the skull base.
Not a fit: Patients with lateral skull-base disease primarily originating in the temporal bone and without central skull-base involvement may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of sinonasal and skull-base tumors, potentially leading to improved patient outcomes.
How similar studies have performed: While sinonasal and skull-base tumors are rare, similar studies have provided valuable insights into their management, suggesting that this approach could yield beneficial results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * sinonasal and/or skull-base cancer * sinonasal disease expanding through the skull-base * the patient's written informed consent Exclusion Criteria: * lateral skull-base disease primarily originating in the temporal bone and without central skull-base involvement
Where this trial is running
Ljubljana, Ljubljana
- University Medical Centre Ljubljana — Ljubljana, Ljubljana, Slovenia (Recruiting)
Study contacts
- Study coordinator: Domen Vozel, MD, PhD
- Email: domen.vozel@kclj.si
- Phone: +38641747865
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.